Table 1 Characteristics of randomized controlled trials included in the systematic review and in each network of primary outcomes.
Characteristic | Systematic review | Network meta-analysis | ||||
|---|---|---|---|---|---|---|
Efficacy network | Acceptability network | |||||
Number of studies | 52 | 25 | 26 | |||
Number of patients included | 4361 | 1925 | 1955 | |||
Women % | 69.7 | 67 | 68.2 | |||
Mean age (years) | 43.0 | 50.6 | 46.3 | |||
N | % | N | % | N | % | |
Year of publication | ||||||
1990–2000 | 3 | 5.8 | 2 | 8 | 2 | 7.7 |
2001–2010 | 10 | 19.2 | 9 | 36 | 10 | 38.5 |
2011–2020 | 28 | 53.8 | 13 | 52.0 | 12 | 46.2 |
2020–2023 | 11 | 21.2 | 1 | 4 | 2 | 7.7 |
N sessions/modules | ||||||
1–6 | 8 | 15.4 | 5 | 20 | 5 | 19.2 |
7–12 | 24 | 46.2 | 9 | 36 | 10 | 38.5 |
13–29 | 18 | 34.6 | 9 | 36 | 9 | 34.6 |
Unclear | 2 | 3.8 | 2 | 8 | 2 | 7.7 |
Risk of bias | ||||||
High | 13 | 25.0 | 5 | 20 | 5 | 19.2 |
Some concerns | 26 | 50.0 | 11 | 44 | 13 | 50 |
Low | 13 | 25.0 | 9 | 36 | 8 | 30.8 |
